Abstract: An automatic system updating apparatus and method are provided, which identifies the event of system update and collects the updating results to the allowlist. The apparatus determines whether at least one pending event intercepted from a file system belongs to a system update event based on a plurality of update rules. The apparatus executes the at least one pending event and generates at least one executable file corresponding to the at least one pending event in response to the at least one pending event belonging to the system update event, and the new generated at least one executable file is not included in an allowlist. The apparatus adds the at least one executable file corresponding to the at least one pending event to the allowlist based on a security setting.

Abstract: An electronic device for assisting driver in recording images is introduced. In the electronic device, a panoramic camera unit is installed on a transportation vehicle to capture an initial video. A positioning unit detects a real-time location of the transportation vehicle. A database stores scenic spot information including multiple scenic spot locations. An intelligence processing unit receives the initial video and uses artificial intelligence to identify a user's image and an image of the scenic spot to be locked at the scenic spot location. The intelligence processing unit receives the real-time location and determines the direction of travel. The intelligence processing unit reads the scenic spot information and determines a viewing range of the transportation vehicle entering the scenic spot location based on the real-time location and the direction of travel to capture a time period within the viewing range from the initial video and crop a recorded video.

Abstract: A porous film is formed by reacting polyamic acid and multi-isocyanate, and the polyamic acid is formed by reacting 1 to 20 parts by mole of (a1) first diamine having a hydroxyl group, 80 to 99 parts by mole of (a2) second diamine without any hydroxyl group, and 100 parts by mole of (b) dianhydride. The multi-isocyanate and (b) dianhydride have a molar ratio of 0.25:100 to 20:100. The porous film has an average pore size of 500 nm to 2000 nm.

Abstract: Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.

Abstract: Disclosed herein are muscle implants and methods of making muscle implants comprising one or more decellularized muscle matrices. The muscle matrices can be provided in a particulate form suitable for injection or implantation.

Abstract: A detection system for determining whether an update of at least one application installed on at least one whitelisted host is legitimate is provided. The system includes an update management server and update detectors installed with the application(s). During a process that software automatic update occurs in each update detector and a corresponding update installation package is executed, the executed update installation package generates at least one updater corresponding to each application. Each update detector transmits report information which includes the information of the at least one updater and sampled executable files to the update management server. The update management server obtains a number of update detectors, having performed the update operation of each application, according to the report information of each update detector. If the number is greater than or equal to a threshold value, it is determined that the update is legitimate.

Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.

Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.

Abstract: Methods of forming a composition for treatment, compositions for treatment, and methods of treatment with the compositions are provided. The methods can include coating a synthetic material substrate with a biologic material. A portion of the biologic material can be acid-swelled.

Abstract: Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.

Abstract: Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.

Abstract: A method for preventing malicious software from attacking files of a computer system includes the following steps. Whether a file type of a specific file corresponding to an input/output (I/O) request is a to-be-backed-up file type is checked, wherein the to-be-backed-up file type belongs to one of multiple predetermined file types susceptible to malicious software attack. When the file type of the specific file is the to-be-backed-up file type, a backup already tag in a file context tag structure of the specific file is checked. When the backup already tag shows that the specific file has not been backed up, a backup process is performed for the specific file.

Abstract: A detection system for determining whether an update of at least one application installed on at least one whitelisted host is legitimate is provided. The system includes an update management server and update detectors installed with the application(s). During a process that software automatic update occurs in each update detector and a corresponding update installation package is executed, the executed update installation package generates at least one updater corresponding to each application. Each update detector transmits report information which includes the information of the at least one updater and sampled executable files to the update management server. The update management server obtains a number of update detectors, having performed the update operation of each application, according to the report information of each update detector. If the number is greater than or equal to a threshold value, it is determined that the update is legitimate.

Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.

Abstract: The present application relates to a polymeric material coating with a combination of acellular tissue matrix particles, transglutaminase, and an at least partially denatured collagen. Methods of producing the coated material and methods of treatment using the coated material are provided.

Abstract: A system and method for synchronizing publication and subscription of message queues are provided. The method includes: providing a message broker cluster including a plurality of message brokers each having a buffer queue and a data queue; as any one of the message brokers requests a synchronization requirement, selecting, by an orchestration server, one of the message brokers in the message broker cluster to perform data synchronization; setting a data read-lock to the data queue of the selected message broker sequentially to write data contents in the buffer queues of all of the plurality of message brokers into the data queue of the selected message broker; and copying the complete data contents in the data queue of the selected message broker to the data queues of the other message brokers, allowing the data contents in the data queues of each of the message brokers to be consistent.

Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.

Abstract: Methods of forming a composition for treatment, compositions for treatment, and methods of treatment with the compositions are provided. The methods can include coating a synthetic material substrate with a biologic material. A portion of the biologic material can be acid-swelled.

Abstract: A system and method for synchronizing publication and subscription of message queues are provided. The method includes: providing a message broker cluster including a plurality of message brokers each having a buffer queue and a data queue; as any one of the message brokers requests a synchronization requirement, selecting, by an orchestration server, one of the message brokers in the message broker cluster to perform data synchronization; setting a data read-lock to the data queue of the selected message broker sequentially to write data contents in the buffer queues of all of the plurality of message brokers into the data queue of the selected message broker; and copying the complete data contents in the data queue of the selected message broker to the data queues of the other message brokers, allowing the data contents in the data queues of each of the message brokers to be consistent.

Abstract: Methods of forming a composition for treatment, compositions for treatment, and methods of treatment with the compositions are provided. The methods can include coating a synthetic material substrate with a biologic material. A portion of the biologic material can be acid-swelled.